GlobeNewswire

Le KFSH de Riyad figure parmi les 5 % des meilleurs établissements de santé au monde pour le tourisme médical selon le classement 2027 de Newsweek
06/11/2026
RIYAD, Arabie saoudite, 06 nov. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSH) de Riyad se classe parmi les 5 % des meilleurs établissements de santé répertoriés dans l’édition [...]
Avance Clinical Brings 30 Years of Early-Phase and Therapeutic Leadership to European Biotechs at BIO-Europe 2026
06/11/2026
Australian fast-start pathway, four Centers of Excellence and a GlobalReady model that takes programs from first-in-human to global Phase II without changing CROs ADELAIDE, Australia, Nov. 06, 2026 (GLOBE NEWSWIRE) -- [...]
MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.
06/11/2026
Approval extends existing U.K. indication for Joenja to eligible children aged 4 to 11 who weigh at least 27 kg Joenja is expected to become available to patients covered by the expanded indication in February 2027 [...]
Orchestra BioMed Announces Pricing of Public Offering
06/11/2026
NEW HOPE, Pa., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients [...]
Global Health Congress 2026 Draws 625+ Leaders From 25 Countries to New York, Names Venture Forum Winners and Announces National and International Expansion
06/11/2026
Second annual Congress at the Yale Club of New York City unites health system CEOs, physicians, technologists and investors; Healthcare Shark Tank led by Robert Herjavec fields 360+ startup applications from 35+ [...]
South San Jose Family Dentistry Launches Under New Owner Dr. Dillon Chang, Continuing 40 Years as a Family Dentist in San Jose
06/11/2026
Following Dr. Les M. Wong's retirement after 40 years at the Blossom Hill Road location, the practice formerly known as San Jose Smile Design has new ownership and a new name and brand, with the same location, phone [...]
MediPharm Labs Achieves Critical European Regulatory Milestone Supporting Commercialization of Proprietary Metered-Dose Cannabis Inhaler Platform
06/11/2026
Positive Article 117 Notified Body Opinion satisfies a key EU regulatory requirement for an advanced cannabis drug-device combination product and supports planned commercialization in the UK and Europe TORONTO, Nov. 05 [...]
Ossium Health to Present One-Year Outcomes in Highly Mismatched Organ Donor Bone Marrow Transplants at ASH 2026
06/11/2026
SAN FRANCISCO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Ossium Health, a bioengineering company that built the world's first bank of organ donor-derived bone marrow, today announced that four abstracts have been selected for [...]
CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2026
05/11/2026
SAN RAMON, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report fourth quarter and full year 2026 financial results on Thursday [...]
Cytek Aurora® Evo System Wins BioTech Breakthrough Award for Drug Discovery Innovation of the Year
05/11/2026
FREMONT, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that its Cytek Aurora ® Evo system has been named Drug Discovery Innovation of the [...]
Nkarta Reports Third Quarter 2026 Financial Results and Provides Business Update
05/11/2026
Initial clinical data for NKX019 in idiopathic inflammatory myopathy (myositis) and systemic sclerosis (scleroderma) to be presented at ACR Convergence 2026 Cash balance of $216.0 million on September 30, 2026, [...]
Satellos to Host Investor Call to Provide an Update on Clinical and Regulatory Strategy for the BASECAMP Phase 2 Pediatric Study
05/11/2026
Company to host a conference call and audio webcast tomorrow at 8:00 a.m. ET TORONTO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage biotechnology company [...]
Tarsus to Participate in Upcoming Investor Conferences
05/11/2026
IRVINE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to attend the following upcoming investor conferences: Guggenheim 3 rd Annual [...]
BioAge Labs Reports Third Quarter 2026 Financial Results and Provides Business Updates
05/11/2026
First participant dosed in QUELL-DME, a Phase 2 trial of BGE-102, a potential best-in-class oral NLRP3 inhibitor, in diabetic macular edema; topline results anticipated in the second half of 2027 QUELL-CV, a Phase 2 [...]
Elutia Reports Third Quarter 2026 Results: As Plastic Surgeons Cite Infection Risk in Every Breast Research Session During National Meeting, NXT-41x Heads to FDA This Quarter, Fully Funded Through Launch
05/11/2026
Infection is a Major Unmet Need in Plastic and Reconstructive Surgery: Infection risk was cited in all 11 breast research sessions at the American Society of Plastic Surgeons’ annual meeting, with serious infection [...]
CytomX Therapeutics Announces Q3 2026 Financial Results and Provides Business Update
05/11/2026
- Varsetatug masetecan (Varseta-M) granted FDA Fast Track designation for relapsed/refractory metastatic colorectal cancer - - Phase 1 monotherapy data update in metastatic colorectal cancer (mCRC) expected in January [...]
Nephros Announces Strong Third Quarter 2026 Financial Results
05/11/2026
Year Over Year Net Revenue Growth of 18% and Core Programmatic Revenue Growth of 8% for the Three Months Ended September 30, 2026 SOUTH ORANGE, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a [...]
TerrAscend Reports Third Quarter 2026 Financial Results
05/11/2026
Q3 2026 Net Revenue of $68.2 Million, Up 4.8% Year-Over-Year Q3 2026 Gross Profit Margin of 52.3%, Up 20 Basis Points Year-Over-Year Q3 2026 Net Cash Provided from Continuing Operations of $8.8 Million, Representing 17. [...]
Gyre Therapeutics Reports Third Quarter 2026 and Year-to-Date Financial Results with Business Updates
05/11/2026
Q3 2026 revenue of $32.9 million; GAAP basic EPS: $(0.04) Full year 2026 revenue guidance of $100.5 to $111.0 million affirmed SAN DIEGO, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Gyre Therapeutics, Inc. (Gyre, Gyre [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum